Deucravacitinib

Deucravacitinib
Product Description

Deucravacitinib is a first-in-class, oral, allosteric tyrosine kinase 2 (TYK2) inhibitor that selectively targets the enzyme's regulatory domain to suppress inflammatory cytokine pathways (IL-23, IL-12, Type I IFNs) while sparing JAK1–3. Approved for the treatment of moderate-to-severe plaque psoriasis, it is widely utilized across pharmaceutical research as a reference standard, active pharmaceutical ingredient (API) benchmark, and analytical control in DMPK, bioanalytical LC-MS/MS assay development, and investigative pipelines for autoimmune conditions like psoriatic arthritis and systemic lupus erythematosus.

CLEARSYNTH LABS LIMITED

  • Country/Region:
    India
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
Analytical Services
API Producer
Biopharmaceutical
Chemical Development
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer
Pharmacy
Specifications
  • CAS Registry Number
    1609392-27-9

CLEARSYNTH LABS LIMITED

  • Country/Region:
    India
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
Analytical Services
API Producer
Biopharmaceutical
Chemical Development
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer
Pharmacy

More Products from CLEARSYNTH LABS LIMITED (62)

  • Domperidone EP Impurity A

    Product Domperidone EP Impurity A

    Intermediate and metabolite of the gastrokinetic and antinauseant drug Domperidone.
  • Sulfacetamide Sodium

    Product Sulfacetamide Sodium

    An antibiotic that blocks synthesis of dihydrofolic acid by inhibiting the enzyme dihydropteroate synthase
  • Tamoxifen

    Product Tamoxifen

    Tamoxifen is a selective estrogen response modifier (SERM), protein kinase C inhibitor and anti-angiogenetic factor. Tamoxifen is a prodrug that is metabolized to active metabolites 4-hydroxytamoxifen (4-OHT) and endoxifen by cytochrome P450 isoforms CYP2D6 and CYP3A4. In breast cancer, the gene repressor ...
  • 2,2-Dipyridylamine

    Product 2,2-Dipyridylamine

    A metal-complexing agent; an effective iron chelating agent to help protect against UVB radiation. An impurity of Chlorpheniramine Maleate . ;Impurity in commercial preparations of Chlorpheniramine.
  • Tert-butanol-d9

    Product Tert-butanol-d9

    Tert-Butanol-d₉ ((CD₃)₃COD) is a high-purity deuterated solvent and versatile isotope-labeled building block used in the synthesis of stable isotope-labeled pharmaceuticals, intermediates, and analytical reference standards. It enables the efficient incorporation of deuterated tert-butyl groups into target...
  • Bromocyclopentane-d9

    Product Bromocyclopentane-d9

    Bromocyclopentane-d₉ is a high-purity deuterated alkyl bromide widely used as a versatile building block in the synthesis of stable isotope-labeled pharmaceuticals, intermediates, and analytical reference standards. It enables the efficient introduction of a deuterated cyclopentyl group into complex organi...
  • Deutetrabenazine

    Product Deutetrabenazine

    Deutetrabenazine is a first-in-class, orally bioavailable deuterated vesicular monoamine transporter 2 (VMAT2) inhibitor approved for the treatment of chorea associated with Huntington’s disease and tardive dyskinesia. 
  • Deutivacaftor

    Product Deutivacaftor

    Deutivacaftor  is an orally active, deuterated cystic fibrosis transmembrane conductance regulator (CFTR) potentiator designed to improve salt and water transport across cell membranes. As a deuterium-substituted analogue of ivacaftor, it utilizes targeted carbon-deuterium bonds to resist CYP3A-mediat...
  • Methyl boronic-d3

    Product Methyl boronic-d3

    Methylboronic Acid-d₃ (CD₃B(OH)₂) is a high-purity deuterated organoboron building block widely used in the synthesis of stable isotope-labeled pharmaceuticals, advanced intermediates, and analytical reference standards. It is an essential reagent for Suzuki–Miyaura cross-coupling reactions, enabling the e...
  • Methyl iodide-d3

    Product Methyl iodide-d3

    Methyl iodide-d₃ (CD₃I) is a high-purity deuterated methylating reagent widely used in the synthesis of stable isotope-labeled pharmaceuticals, intermediates, metabolites, and analytical reference standards. It enables the efficient incorporation of a deuterated methyl (–CD₃) group into complex organic mol...
  • Methyl tosylate-d3

    Product Methyl tosylate-d3

    Methyl Tosylate-d₃ (CD₃OTs) is a high-purity deuterated methylating reagent widely used in the synthesis of stable isotope-labeled pharmaceuticals, intermediates, and analytical reference standards. It enables the efficient introduction of a deuterated methyl (–CD₃) group into target molecules, making it a...
  • Methylamine-d3 HCl

    Product Methylamine-d3 HCl

    Methylamine-d₃ Hydrochloride serves as a key deuterated building block for introducing a CD₃-labeled methylamine moiety into complex organic molecules. It is extensively used in the preparation of deuterated drug candidates, impurities, and metabolites, including compounds such as: Deucravacitinib-d₃ ...

CLEARSYNTH LABS LIMITED resources (1)

  • Video Clearsynth Intro Video

    Clearsynth Labs Limited is a technology-based, research-driven, innovation-led enterprise specializing in deuterium chemistry and stable isotopes. Headquartered in Mumbai, with an R&D center in Hyderabad and a CDMO facility in Karnataka, alongside operations in Canada and the USA, we deliver solutions from milligram-scale R&D to multi-ton manufacturing. Our expertise spans deuterated APIs, intermediates, impurities, and reference standards. Backed by strong IP and 350+ scientists, we partner with innovators and generics across CDMO and CMO segments, committed to precision, quality, and advancing next-generation isotopic solutions for global pharmaceutical needs.